logo

For the Inventor, By the Inventor

La Jolla, CA, United States of America

La Jolla Cancer Research Foundation


USPTO Granted Patents = 142

Forward Citations = 2,736

Loading Chart...
Loading Chart...

91 inventors (with patents filed for the assignee):

goldMedal Erkki I Ruoslahti (52 out of 133 patents)

silverMedal Michael D Pierschbacher (44 out of 47 patents)

bronzeMedal John C Reed (13 out of 85 patents)

4.  William S Craig (13 out of 15 patents)

5.  Soan Cheng (11 out of 31 patents)

6.  Minoru Fukuda (11 out of 24 patents)

7.  Takaaki Sato (8 out of 10 patents)

8.  Magnus Pfahl (7 out of 24 patents)

9.  Juerg F Tschopp (7 out of 17 patents)

10.  Michiko N Fukuda (6 out of 16 patents)

11.  David S Lukeman (6 out of 6 patents)

12.  Eva Engvall (6 out of 6 patents)

13.  Marti F Bierhuizen (6 out of 7 patents)

14.  Yu Yamaguchi (5 out of 6 patents)

15.  Erkki Koivunen (5 out of 6 patents)


Core Competencies:
Bcl-2
Extracellular Matrix
Integrin-Binding Peptides
Cell Adhesion Peptides
Thrombosis Treatment
Fibrotic Conditions
Transcriptional Activators
Antithrombotic Agents
Wound Healing
Trophinin Proteins
Polypeptide Conjugates
Gene Modulation

142 patents:

1. 7427495 - Methods of using Bcl-2 for the therapeutic treatment and prevention of diseases (2008-09-23),
2. 7214375 - Methods of decreasing the accumulation of extracellular matrix associated with glomerulonephritis with anti-TGF-β-specific antibodies (2007-05-08),
3. 7067619 - Integrin-binding peptides (2006-06-27),
4. 6743892 - Molecules that home to a selected organ in vivo (2004-06-01),
5. 6537553 - Leukosialin: Ig fusion proteins (2003-03-25),
6. 6521594 - Method and composition for treating thrombosis (2003-02-18),
7. 6436900 - Methods of treating a pathology or a fibrotic condition by administering decorin (2002-08-20),
8. 6395873 - Method and composition for treating thrombosis (2002-05-28),
9. 6353090 - Conformationally stabilized cell adhesion peptides (2002-03-05),
10. 6333407 - Matrix-associating DNA-binding protein, nucleic acids encoding the same and methods for detecting the nucleic acids (2001-12-25),
11. 6242577 - Isolation and use fibronectin receptor (2001-06-05),
12. 6180610 - Tetrapeptide (2001-01-30),
13. 6172187 - CD40 associated proteins (2001-01-09),
14. 6100243 - Method of sensitizing tumor cells with adenovirus E1A (2000-08-08),
15. 6100236 - Method and composition for treating thrombosis (2000-08-08),
La Jolla Cancer Research Foundation is a non-profit organization dedicated to advancing cancer research, prevention, and treatment. With a team of renowned scientists and state-of-the-art facilities, we strive to make breakthrough discoveries and develop innovative therapies to combat cancer.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

142 Patents

#3 in La Jolla, CA

#616 in California

#2,650 in US

#5,573 in the World

...
La Jolla, CA, United States of America

La Jolla Cancer Research Foundation

Forward Citations = 2,736

91 inventors:

goldMedal Erkki I Ruoslahti (52 out of 133 patents)

silverMedal Michael D Pierschbacher (44 out of 47 patents)

bronzeMedal John C Reed (13 out of 85 patents)

4.  William S Craig (13 out of 15 patents)

5.  Soan Cheng (11 out of 31 patents)

Please report any incorrect information to support@idiyas.com
Loading…